📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

EverCommerce Inc., together with its subsidiaries, provides integrated software-as-a-service solutions for service-based small and medium-sized businesses in the United States and internationally.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific → Stable 4 quarters analysed

Q2 2025

Confident Specific

Management used language such as 'strong results', 'exceeded guidance', 'record attach rates', and 'really good results' to describe the quarter, while providing specific figures like 230 bps margin expansion, 7.4% pro forma revenue growth, and 29% year-over-year growth in customers utilizing more than one solution.

Q3 2025

Confident Specific

Management uses precise figures (EBITDA beat top of range, 140bps margin expansion, 8% core SaaS growth) and upbeat language ('incredible momentum', 'tremendous excitement'). No hedging or defensiveness evident.

Q4 2025

Confident Specific

Management repeatedly used specific data points (revenue $151.2M, Adj EBITDA $44.2M, 99.1% satisfaction rate, 8-min time savings, 17.4% TPV growth in top solutions) to reinforce execution on AI and cross-sell, with language like 'tremendous positive change' and 'met or exceeded financial targets'.

Q1 2026 latest

Confident Specific

management repeatedly cited specific numbers (32% growth in multi-product adoption, 19.8% TPV growth in top six solutions, $13.9M buyback) and provided detailed customer case studies for both EverPro (ZyraTalk AI voice reception) and EverHealth (AI Scribe). Language was forward-looking but grounded in executed results.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis appears stronger after this call. Management delivered in-line Q1 results with explicit proof points of accelerating multi-product adoption (32% growth) and AI-driven customer stories that demonstrate real ARPU expansion potential. The back-half acceleration narrative is supported by pricing actions, go-to-market improvements, and AI monetization, though the legacy payments drag remains an overhang. Key metrics to watch next quarter: whether net revenue retention inflects above 95%, the pace of ZyraTalk cross-sell beyond Service Fusion, and if top-six solutions TPV growth continues above 19%. The unchanged full-year guidance implies confidence but leaves limited room for error. Overall, the call reinforces that the company is transitioning from investment to monetization in AI, which could re-rate the stock if growth reaccelerates.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →

📊 MIXED EverCommerce Q1 2026: $147.5M revenue, 745k customers, 3.6% growth, 27.6% EBITDA margin.

Revenue & Profitability

Q1 2026 total revenue was $147.5 million, up 3.6% year-over-year. Subscription and transaction revenue (primary recurring) was $142.1 million. Adjusted EBITDA was $40.7 million (27.6% margin). Adjusted gross profit was $114.8 million (77.8% margin). Pro forma LTM revenue was $596 million, with 5.2% pro forma growth. Cash flow from operations was $24.6 million; levered free cash flow was $16.6 million.

Outlook

Management sees healthy demand and stable sales cycles across both EverPro and EverHealth. They note improving leading indicators such as payments enablement and multi-product adoption. The company reiterated its full-year 2026 guidance (revenue $612-$632 million, adjusted EBITDA $183-$191 million), expecting back-half acceleration from pricing actions, AI monetization, and go-to-market investments.

Growth Drivers

Key growth levers include multi-product adoption (32% year-over-year growth in active multi-solution customers to ~131,000), AI features like ZyraTalk (AI voice reception) and EverHealth Scribe, and payments expansion in the top six solutions (TPV up 19.8%, payments revenue up 10%). Outbound sales are increasing as a new channel. Net revenue retention overall was 95%, with multi-solution customers above 100%.

Balance Sheet & CapEx

Not discussed in this earnings call.

Margins

Adjusted EBITDA margin was 27.6% in Q1, and 29.7% on an LTM basis. Management expects further margin expansion from higher-margin incremental revenue (pricing actions, AI add-ons, payments growth). Adjusted operating expenses were 50.3% of revenue in Q1 (up year-over-year due to targeted investments), but flat at 47.9% on an LTM basis.

Key Risks

Declining third-party partner revenue within the legacy payments business is a headwind, lowering overall net revenue retention (95%). The company faces execution risk in transitioning to outbound sales and achieving back-half acceleration. Leverage is manageable (2.2x net leverage) but debt outstanding is $525 million.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-08-05

Q2 2026 revenue grew 2.7% YoY to $152M, with Adjusted EBITDA exceeding guidance. Leadership transitioned to Alex Goor as CEO. Full-year results are expected at the lower end of guidance due to slower EverPro customer acquisition, but growth is anticipated to accelerate in Q4.

Q1 2026 Q1 2026 2026-05-07

Q1 2026 revenue grew 3.6% year-over-year to $147.5M, with adjusted EBITDA margin at 27.6%. AI integration and multi-product adoption drove customer expansion, while guidance for 2026 remains unchanged, expecting revenue of $612–632M and adjusted EBITDA of $183–191M.

Q4 2025 Q4 2025 2026-03-12

Delivered strong Q4 and full-year 2025 results, exceeding guidance with 5.2% revenue growth and robust margins. AI-driven product innovation and operational efficiency are fueling growth, with 2026 guidance reflecting continued investment in AI and payments.

Q3 2025 Q3 2025 2025-11-06

Q3 2025 revenue grew 5.3% year-over-year to $147.5 million, with Adjusted EBITDA margin expanding to 31.5%. Strategic focus sharpened by the sale of marketing tech and the Zyratok AI acquisition, supporting long-term growth and margin expansion. Guidance for 2025 was narrowed and raised at the top end.

Q2 2025 Q2 2025 2025-08-06

Q2 revenue and adjusted EBITDA exceeded guidance, with strong growth in payments and multi-product adoption. Full-year EBITDA guidance was raised, while revenue guidance remains prudent despite robust first-half results. AI initiatives and operational efficiencies continue to drive margin expansion.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.